REVELATION BIOSCIENCES INC(NASDAQ:REVB) stock News

REVB Latest News, Press Relases and Analysis

All

Press Releases

15 days ago - By: Benzinga - Mentions: GRI PACS XCUR MSPR ...

12 Health Care Stocks Moving In Thursday's Intraday Session

15 days ago - By: ACCESS Newswire

Revelation Biosciences Inc. Announces Exercise of Warrants for $9.6 Million in Gross Proceeds

16 days ago - By: Benzinga - Mentions: ACTU CAMP INTS ONC ...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

16 days ago - By: ACCESS Newswire

Revelation Biosciences Announces Special Webcast to Review Positive Top-line Clinical Data

17 days ago - By: ACCESS Newswire

Reminder - Webcast/Conference Call to Discuss Fantastic PRIME Phase 1b Top-line Data

17 days ago - By: Stocktwits

Revelation Biosciences Stock Slides 17% After Company Reports 3 Severe Adverse Events In Early Stage Trial Of Inflammation Drug

17 days ago - By: ACCESS Newswire

Revelation Biosciences Announces Groundbreaking Top-line Results from PRIME Clinical Study

2 months ago - By: Revelation Biosciences, Inc.

Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2025

2 months ago - By: Revelation Biosciences, Inc.

Revelation Biosciences, Inc. Congratulates Its Former Chairman of the Board, George Tidmarsh, on His Appointment as the Head of the FDA Center for Drug Evaluation and Research

2 months ago - By: Revelation Biosciences, Inc.

Revelation Biosciences Inc. Completes Dosing of Patients in PRIME Study

3 months ago - By: Stocktwits

Revelation Biosciences Stock Sinks 12% After Reverse Split Reveal; Retail Traders Eye ‘Bigger News’

3 months ago - By: Revelation Biosciences, Inc.

Revelation Biosciences Inc. Announces 1-for-3 Reverse Stock Split Effective July 7, 2025

4 months ago - By: Yahoo Finance - Mentions: 1456 URBN KSS DECK ...

S&P lowers outlook on Volvo Cars rating citing US tariffs, competition in China

4 months ago - By: Yahoo Finance - Mentions: ESLT CTKB KROS VREX ...

Revelation Biosciences, Inc. (REVB) Raises $4M in Public Offering

4 months ago - By: Revelation Biosciences, Inc.

Revelation Biosciences, Inc. Announces Closing of $4 Million Public Offering

4 months ago - By: Revelation Biosciences, Inc.

Revelation Biosciences, Inc. Announces Pricing of $4 Million Public Offering

4 months ago - By: Revelation Biosciences, Inc.

Revelation Biosciences Announces Retirement of George Tidmarsh, MD, PhD from Board of Directors

5 months ago - By: Revelation Biosciences, Inc.

Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2025

5 months ago - By: Revelation Biosciences, Inc.

Revelation Biosciences to Develop Gemini for Infection in Severe Burn Patients

6 months ago - By: Yahoo Finance - Mentions: TSLA

REVELATION BIOSCIENCES INC (REVB) Stock News

REVB Latest News, Press Relases and Analysis

12 Health Care Stocks Moving In Thursday's Intraday Session

Revelation Biosciences Inc. Announces Exercise of Warrants for $9.6 Million in Gross Proceeds

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Revelation Biosciences Announces Special Webcast to Review Positive Top-line Clinical Data

Reminder - Webcast/Conference Call to Discuss Fantastic PRIME Phase 1b Top-line Data

Revelation Biosciences Stock Slides 17% After Company Reports 3 Severe Adverse Events In Early Stage Trial Of Inflammation Drug

Revelation Biosciences Announces Groundbreaking Top-line Results from PRIME Clinical Study

Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2025

Revelation Biosciences, Inc. Congratulates Its Former Chairman of the Board, George Tidmarsh, on His Appointment as the Head of the FDA Center for Drug Evaluation and Research

Revelation Biosciences Inc. Completes Dosing of Patients in PRIME Study

Revelation Biosciences Stock Sinks 12% After Reverse Split Reveal; Retail Traders Eye ‘Bigger News’

Revelation Biosciences Inc. Announces 1-for-3 Reverse Stock Split Effective July 7, 2025

S&P lowers outlook on Volvo Cars rating citing US tariffs, competition in China

Revelation Biosciences, Inc. (REVB) Raises $4M in Public Offering

Revelation Biosciences, Inc. Announces Closing of $4 Million Public Offering

Revelation Biosciences, Inc. Announces Pricing of $4 Million Public Offering

Revelation Biosciences Announces Retirement of George Tidmarsh, MD, PhD from Board of Directors

Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2025

Revelation Biosciences to Develop Gemini for Infection in Severe Burn Patients

Why Revelation Biosciences Inc. (REVB) Went Down On Thursday?